Clinical Trials Directory

Trials / Sponsors / Arthrosi Therapeutics

Arthrosi Therapeutics

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingEvaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Gout, Gouty Arthritis, Hyperuricemia
Phase 22025-12-03
Active Not RecruitingPhase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
Gout, Arthritis, Gouty, Hyperuricemia
Phase 32025-03-11
Active Not RecruitingPhase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Gout, Arthritis, Gouty, Hyperuricemia
Phase 32024-06-26
CompletedPhase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Topha
Gout, Arthritis, Gouty, Hyperuricemia
Phase 22022-08-12
CompletedPhase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
Gout, Arthritis, Gouty, Hyperuricemia
Phase 22021-11-16
CompletedPharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
Renal Impairment
Phase 12021-01-14
CompletedSingle-dose AME Study With [14C]AR882 in Healthy Male Subjects
Healthy Volunteers
Phase 12020-07-16
CompletedPhase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients
Gout Patients
Phase 22020-02-03
CompletedMultiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers
Healthy Volunteers
Phase 12019-06-28
CompletedThe Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males
Healthy Volunteers
Phase 12019-01-22